Company: APXIF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026189
Chunk: 432

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 432
---
, the holders of the Registrable Securities (as defined in the Registration Rights and Lock-Up Agreement) shall
have customary demand and piggyback registration rights in connection with the Company Shares held by such holders. Additionally,
the Company Shares held by each party to the Registration Rights and Lock-Up Agreement will, subject to certain exceptions, be
subject to a lock-up until (i) the date that is twelve (12) months from the Closing Date, and (ii) such date on which the Company
completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders of the Company
having the right to exchange their Company Shares for cash, securities or other property, provided that if the share price of the
Company Shares exceeds $12.00 per Company Share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the
like) for any 20 trading days within any 30-day trading period, 50% of the Company Shares held by any given party to the
Registration Rights and Lock-Up Agreement shall be released from the lock-up. 

8

Promissory Notes

On August 26, 2024, the Company issued an unsecured
promissory note (the “First Bioceres Note”) in the principal amount of $446,000 to Bioceres LLC (“Bioceres”),
an indirect shareholder of OmnigenicsAI. The Note bears interest at 20% per annum. The Company shall repay all interested accrued and
the principal balance on the date on which the Company consummates its initial business combination. The First Bioceres Note is subject
to customary events of default, the occurrence of certain of which automatically triggers the unpaid principal balance of the First Bioceres
Note as well as all accrued interest and all other sums payable with regard to the First Bioceres Note becoming immediately due and payable.

On November 7, 2024, the Company issued an unsecured
promissory note in the principal amount of $700,000 to Bioceres (the “Second Bioceres Note”
and, together with the First Bioceres Note, the “Bioceres Notes”). The Company
shall repay all interested accrued and the principal balance on the date on which the Company consummates its initial business combination.

As of December 31, 2024, $914,615 has been drawn
under the Bioceres Notes.

Fifth Extension

On December 4,